The Performances of Spectral Domain Optical Coherence Tomography (OCT) for Distinguishing Glaucomatous Eyes - Full Text View

The Performances of Spectral Domain Optical Coherence Tomography (OCT) for Distinguishing Glaucomatous Eyes (cirrusOCT)

This study has been completed.

First Received: February 10, 2010 Last Updated: March 22, 2010 History of Changes

Sponsor:	Prince of Songkla University
Information provided by:	Prince of Songkla University
ClinicalTrials.gov Identifier:	NCT01067482

Purpose

The purpose of this study is to evaluate performances of each parameters of spectral domain (Cirrus) optical coherence tomography for distinguishing between normal eyes, glaucoma suspect and glaucomatous eyes

Condition
Glaucoma Patient Glaucoma Suspect Patient Normal Population RNFL Thickness by Location Macular Thickness by Location

Study Type:	Observational
Study Design:	Time Perspective: Prospective
Official Title:	The Performances of Spectral Domain Optical Coherence Tomography for Distinguishing Between Normal Eyes, Glaucoma Suspect and Glaucomatous Eyes

Resource links provided by NLM:

Genetics Home Reference related topics: early-onset glaucoma

MedlinePlus related topics: Glaucoma

U.S. FDA Resources

Further study details as provided by Prince of Songkla University:

Estimated Enrollment:	80
Study Start Date:	September 2009
Study Completion Date:	March 2010
Primary Completion Date:	March 2010 (Final data collection date for primary outcome measure)

Groups/Cohorts
Glaucoma patients
Glaucoma suspect group
Normal population

Detailed Description:

Aim to determine which parameter of cirrus OCT is best sensitivity and specificity for glaucoma detection

Eligibility

Ages Eligible for Study:	18 Years to 80 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes
Sampling Method:	Probability Sample

Study Population

glaucoma patient from glaucoma clinic that is POAG Glaucoma suspect cases normal population case

Criteria

Inclusion Criteria:

BCVA at least 20/60
refractive error +/- 5 D Or astig +/- 3 D
enrolled in 3 population group (glaucoma, glaucoma suspect or normal)

Exclusion Criteria:

VA less than 20/60
marked RF error
previous ocular trauma or surgery
unreliable visual field
poor signal cirrus OCT (less than 7)
other causes of optic nerve or macular disease other than glaucoma

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT01067482

Locations

Thailand, Songkhla, Thailand.
Glaucoma unit , Department of Ophthalmology Faculty of Medicine Prince of Songkla University
Hat-yai,, Songkhla, Thailand., Thailand, 90110

Sponsors and Collaborators

Prince of Songkla University

Investigators

Principal Investigator:

Weerawat Kiddee, MD

Prince of Songkla University

More Information

No publications provided

Responsible Party:	Glaucoma unit , Department of Ophthalmology Faculty of Medicine Prince of Songkla University Hat-yai,, Songkhla, Thailand., Thailand ( Weerawat Kiddee )
ClinicalTrials.gov Identifier:	NCT01067482 History of Changes
Other Study ID Numbers:	EC 52-336-02-1-2
Study First Received:	February 10, 2010
Last Updated:	March 22, 2010
Health Authority:	Thailand: Ethical Committee

Keywords provided by Prince of Songkla University:

OCT
spectral domain cirrus
glaucoma
glaucoma suspect
normal population

Additional relevant MeSH terms:

Glaucoma
Ocular Hypertension
Eye Diseases

ClinicalTrials.gov processed this record on September 01, 2010